Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022

South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthSouth Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022

South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine.

View Premium plansBrowse free archive reports